Financial Contrast: Crescent Capital BDC (NASDAQ:CCAP) versus Core Scientific (NASDAQ:CORZ)

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) and Core Scientific (NASDAQ:CORZGet Free Report) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Valuation & Earnings

This table compares Crescent Capital BDC and Core Scientific”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Crescent Capital BDC $184.13 million 3.93 $83.84 million $2.55 7.65
Core Scientific $502.40 million 9.71 -$1.51 billion ($5.41) -3.23

Crescent Capital BDC has higher earnings, but lower revenue than Core Scientific. Core Scientific is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and recommmendations for Crescent Capital BDC and Core Scientific, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Crescent Capital BDC 0 1 5 0 2.83
Core Scientific 0 0 13 1 3.07

Crescent Capital BDC presently has a consensus target price of $19.17, suggesting a potential downside of 1.81%. Core Scientific has a consensus target price of $18.38, suggesting a potential upside of 5.24%. Given Core Scientific’s stronger consensus rating and higher probable upside, analysts plainly believe Core Scientific is more favorable than Crescent Capital BDC.

Profitability

This table compares Crescent Capital BDC and Core Scientific’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Crescent Capital BDC 47.06% 12.20% 5.57%
Core Scientific N/A N/A N/A

Institutional & Insider Ownership

49.5% of Crescent Capital BDC shares are held by institutional investors. 1.1% of Crescent Capital BDC shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Crescent Capital BDC beats Core Scientific on 8 of the 14 factors compared between the two stocks.

About Crescent Capital BDC

(Get Free Report)

Crescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

About Core Scientific

(Get Free Report)

Core Scientific, Inc. provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment. In addition, the company provides electrical power, repair, and other infrastructure services to operate, maintain, and earn digital assets; and sells mining equipment to customers. Core Scientific, Inc. was founded in 2017 and is headquartered in Dover, Delaware.

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.